Skip to main content
. 2012 Apr 6;3(5):422–426. doi: 10.1021/ml300056y

Figure 1.

Figure 1

Chemical structures of β-lactone NAAA inhibitors, (S)-N-(2-oxo-3-oxetanyl)-3-phenylpropanamide [(S)-OOPP], N-[(2S,3R)-2-methyl-4-oxo-oxetan-3-yl] carbamate (ARN077), and N-[(2S,3R)-2-methyl-4-oxo-oxetan-3-yl]-7-phenyl-heptanamide (ARN768).

HHS Vulnerability Disclosure